Cultivating A Positive Attitude For Lasting Impact. Throughout my journey as an investor, entrepreneur, and an avid learner ...

Timberwolves coach Chris Finch said Edwards always comes in with a good mood, and noted he was one of the most positive ...

today announced the poster presentation of positive results from its first-in-human trial of AMP-303, a novel intradermal injectable treatment for androgenetic alopecia, the most common form of hair ...

DALLAS, April 30, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ: MDAI) (“Spectral AI” or the “Company”), a leading developer of the AI-driven DeepView ® System, which uses multi-spectral imaging ...

DALLAS, April 30, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ: MDAI) (“Spectral AI” or the “Company”), a leading developer of the AI-driven DeepView® System, which uses multi ...

ELISpot-positive cytotoxic T cells and neutralizing antibodies developed when steroids were absent. With steroid-sparing regimens, pancreatic B and T lymphocyte populations were noted on scRNA ...

The featured Genprex-supported abstract to be presented for oral presentation at the ASGCT 28 th Annual Meeting: Gene therapy using recombinant adeno-associated virus (rAAV) offers a promising ...

Cullinan Therapeutics, Inc. announced that it will present results from the REZILIENT1 study of zipalertinib, a treatment for non-small cell lung cancer (NSCLC) patients with EGFR exon 20 ...

VALBY, Denmark, April 4, 2025 /PRNewswire/ -- H. Lundbeck A/S (Lundbeck) will present positive interim results from the open-label extension of the PACIFIC trial investigating bexicaserin ...

H. Lundbeck A/S (Lundbeck) will present positive interim results from the open-label extension of the PACIFIC trial investigating bexicaserin, in addition to new analyses from clinical trials and real ...

"We are delighted to have our academic partners present positive preclinical data on our lead drug candidate, REQORSA, as a potential therapeutic treatment for Ras inhibitor resistant lung cancer ...